Quick Answer
Tonix Pharmaceuticals Holding Corp. reported Net Income of -$124.02 million for fiscal year 2025.
Tonix Pharmaceuticals Holding Corp. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$124.02M | +4.6% |
| 2024 | -$130.04M | -11.5% |
| 2023 | -$116.66M | -5.8% |
| 2022 | -$110.22M | -19.4% |
| 2021 | -$92.29M | -82.9% |
| 2020 | -$50.46M | -76.3% |
| 2019 | -$28.62M | -9.7% |
| 2018 | -$26.09M | -23.5% |
| 2017 | -$21.12M | +45.6% |
| 2016 | -$38.84M | +19.2% |
| 2015 | -$48.05M | -74.0% |
| 2014 | -$27.62M | -153.7% |
| 2013 | -$10.88M | -15.2% |
| 2012 | -$9.45M | -172.3% |
| 2011 | -$3.47M | -76.7% |
| 2010 | -$1.96M | -788.7% |
| 2009 | -$221.0K | -9.4% |
| 2008 | -$202.0K | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$32.01M | -125.2% | -13.2% |
| June 30, 2025 | -$28.27M | +64.1% | -68.0% |
| March 31, 2025 | -$16.83M | -12.7% | -18.4% |
| September 30, 2024 | -$14.21M | +49.2% | +82.0% |
| June 30, 2024 | -$78.78M | -177.8% | -427.3% |
| March 31, 2024 | -$14.94M | +54.7% | +46.6% |
| September 30, 2023 | -$27.98M | +3.5% | +1.3% |
| June 30, 2023 | -$28.36M | -22.5% | +14.1% |
- Tonix Pharmaceuticals Holding Corp. showed an increase of +4.6% in Net Income compared to the prior fiscal year.
- Over the 2008–2025 period, Tonix Pharmaceuticals Holding Corp.’s net income has declined by 61296.5% (from -$202.0 thousand to -$124.02 million).
- The most recent figure is from Tonix Pharmaceuticals Holding Corp.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: